Guidance
Evidence-based recommendations on AposHealth for knee osteoarthritis.
NICE has developed tools and resources, in association with relevant stakeholders, to help organisations put this guidance into practice.
Guidance development process
How we develop NICE medical technologies guidance
If a technology is recommended for use, the specific recommendations are not intended to limit use of other relevant technologies that may offer similar advantages. If the technology is recommended for use in research, the recommendations are not intended to preclude the use of the technology but to identify further evidence which, after evaluation, could support a recommendation for wider adoption.
This guidance updates and replaces NICE’s medtech innovation briefing on AposHealth for knee osteoarthritis (MIB284).